Ryan Runyon, DO
Family Medicine · Princeton, WVNPI 1932115938
Payments from drug & device makers
Across 1,014 payments — averaging $21.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amarin Pharma, Inc.$7K
- AstraZeneca$2K
- Novo Nordisk$1K
- GSK$1K
- Kowa Pharmaceuticals America, Inc.$1K
- Amgen$1K
- plus $7K from 28 others
What the payments were for
- Speaking & faculty fees$5,52026%
- Travel & lodging$1,0115%
- Food & beverage$14,87769%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amarin Pharma, Inc. | 48 | $7,275 |
| AstraZeneca | 133 | $2,482 |
| Novo Nordisk | 97 | $1,371 |
| GSK | 104 | $1,346 |
| Kowa Pharmaceuticals America, Inc. | 118 | $1,215 |
| Amgen | 79 | $1,203 |
| Boehringer Ingelheim | 57 | $916 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 61 | $913 |
| Lilly USA, LLC | 52 | $791 |
| AbbVie(2 entities) | 60 | $725 |
| Merck | 56 | $720 |
| Pfizer | 40 | $551 |
| Abbott | 12 | $339 |
| Esperion Therapeutics, Inc. | 22 | $294 |
| Exact Sciences | 10 | $182 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $143 |
| Teva Pharmaceuticals USA, Inc. | 8 | $112 |
| Johnson & Johnson | 7 | $112 |
| Novartis | 6 | $110 |
| Sanofi-aventis U.S. LLC | 6 | $105 |
| Eisai Inc. | 6 | $92 |
| Boston Scientific | 1 | $73 |
| E.r. Squibb & Sons, L.L.C. | 4 | $60 |
| Shield Therapeutics Inc | 2 | $47 |
| Biohaven Pharmaceuticals, Inc. | 3 | $43 |
| Dexcom, Inc. | 2 | $40 |
| Xeris Pharmaceuticals, Inc. | 2 | $35 |
| Genentech USA, Inc. | 1 | $22 |
| Axonics, Inc. | 1 | $22 |
| Biomerieux Inc | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Tris Pharma Inc | 1 | $16 |
| Medtronic | 1 | $16 |
| Insulet Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Vascepa$6,613
- FARXIGA$174
- SYMBICORT$174
- FreeStyle Libre 2$136
How this compares
$21,421 in reported general payments places this provider in the 95th percentile of 843 family medicine providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 109 | $216,454 |
| JardianceEmpagliflozin | 114 | $173,572 |
| FarxigaDapagliflozin Propanediol | 114 | $138,235 |
| EliquisApixaban | 91 | $113,243 |
| VascepaIcosapent Ethyl | 92 | $81,724 |
| JanuviaSitagliptin Phosphate | 60 | $65,967 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 44 | $63,308 |
| MounjaroTirzepatide | 31 | $62,523 |
| JanumetSitagliptin Phos/Metformin Hcl | 48 | $61,190 |
| XareltoRivaroxaban | 32 | $45,243 |
| Xigduo XrDapaglifloz Propaned/Metformin | 24 | $34,759 |
| TradjentaLinagliptin | 30 | $34,273 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 19 | $29,281 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 76 | $23,534 |
| TrulicityDulaglutide | 14 | $22,692 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $1,371 | $216,454109 claims |
| Boehringer IngelheimJardiance, Tradjenta | $916 | $207,846144 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $2,482 | $159,099125 claims |
| MerckJanuvia, Janumet, Belsomra | $720 | $133,927124 claims |
| PfizerEliquis, Premarin | $551 | $119,043103 claims |
| GSKTrelegy Ellipta, Arexvy, Shingrix | $1,346 | $98,108171 claims |
| Lilly USA, LLCMounjaro, Trulicity | $791 | $85,21545 claims |
| Johnson & JohnsonXarelto | $112 | $45,24332 claims |
| NovartisEntresto | $110 | $14,58714 claims |
| AbbVieSynthroid | $725 | $3,98347 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 843 family medicine providers in West Virginia.
Other family medicine in Princeton
- Phillip PetersonPrinceton$7K
- Wilbur SineMorgantown$179K
- Dorian WilliamsMorgantown$169K
- Julie DetempleSouth Charleston$129K
- Clemente DiazRichwood$127K
- John CornellHuntington$94K
- Mark CucuzzellaHarpers Ferry$59K
- Courtney PilkertonMorgantown$45K
- Isha WoofterClarksburg$27K
- Dominick WoofterClarksburg$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.